ATE186535T1 - Verfahren zur herstellung von omeprazol - Google Patents

Verfahren zur herstellung von omeprazol

Info

Publication number
ATE186535T1
ATE186535T1 AT92202792T AT92202792T ATE186535T1 AT E186535 T1 ATE186535 T1 AT E186535T1 AT 92202792 T AT92202792 T AT 92202792T AT 92202792 T AT92202792 T AT 92202792T AT E186535 T1 ATE186535 T1 AT E186535T1
Authority
AT
Austria
Prior art keywords
bridge
moiety
reaction
substituted
omeprazole
Prior art date
Application number
AT92202792T
Other languages
English (en)
Inventor
Robert Scott Hoerrner
Joel J Friedman
Joseph Sebastian Amato
Thomas Meng-Han Liu
Ichiro Shinkai
Leonard M Weinstock
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE186535T1 publication Critical patent/ATE186535T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT92202792T 1991-09-20 1992-09-12 Verfahren zur herstellung von omeprazol ATE186535T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76456491A 1991-09-20 1991-09-20
US77787391A 1991-10-15 1991-10-15

Publications (1)

Publication Number Publication Date
ATE186535T1 true ATE186535T1 (de) 1999-11-15

Family

ID=27117485

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92202792T ATE186535T1 (de) 1991-09-20 1992-09-12 Verfahren zur herstellung von omeprazol

Country Status (18)

Country Link
US (1) US5391752A (de)
EP (1) EP0533264B1 (de)
JP (1) JPH0720956B2 (de)
KR (1) KR100242622B1 (de)
CN (1) CN1048729C (de)
AT (1) ATE186535T1 (de)
AU (1) AU649355B2 (de)
CA (1) CA2078517C (de)
DE (1) DE69230278T2 (de)
DK (1) DK0533264T3 (de)
ES (1) ES2143468T3 (de)
GR (1) GR3032619T3 (de)
IL (1) IL103156A (de)
MX (1) MX9205333A (de)
NZ (1) NZ244301A (de)
PT (1) PT533264E (de)
WO (1) WO1993006097A1 (de)
YU (1) YU48291B (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
US5504082A (en) * 1992-06-01 1996-04-02 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and pharmaceutical compostions
KR950701921A (ko) * 1992-06-01 1995-05-17 고야 다다시 피리딘 화합물 및 이의 제약학적 용도(pyridine compound and medicinal use thereof)
SE521100C2 (sv) * 1995-12-15 2003-09-30 Astra Ab Förfarande för framställning av en bensimidazolförening
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
CN1053444C (zh) * 1996-03-20 2000-06-14 常州市第四制药厂 奥美拉唑的一种精制方法
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
SK283805B6 (sk) * 1996-09-09 2004-02-03 Slovakofarma, A. S. Spôsob prípravy omeprazolu
SE9704183D0 (sv) 1997-11-14 1997-11-14 Astra Ab New process
US6166213A (en) * 1998-08-11 2000-12-26 Merck & Co., Inc. Omeprazole process and compositions thereof
US6191148B1 (en) 1998-08-11 2001-02-20 Merck & Co., Inc. Omerazole process and compositions thereof
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
DE19951960C2 (de) * 1999-10-28 2002-06-27 Gruenenthal Gmbh Verfahren zur Herstellung als Ulkustherapeutika geeigneter Benzimidazol-Derivate
CN1781918A (zh) * 2001-02-02 2006-06-07 特瓦制药工业有限公司 制备硫酯化合物的方法
KR100783020B1 (ko) * 2001-03-23 2007-12-07 동아제약주식회사 2-메틸클로라이드 피리딘 유도체 및 이를 이용한 벤즈이미다졸 유도체의 제조 방법
CA2450433C (en) * 2001-07-16 2010-05-25 Janssen Pharmaceutica N.V. Improved process for preparing benzimidazole-type compounds
EP1469839A2 (de) * 2002-01-25 2004-10-27 Santarus, Inc. Transmukosale verabreichung von protonenpumpeninhibitoren
US7211590B2 (en) * 2002-08-01 2007-05-01 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
SE0203092D0 (en) * 2002-10-18 2002-10-18 Astrazeneca Ab Method for the synthesis of a benzimidazole compound
US7507829B2 (en) 2002-12-19 2009-03-24 Teva Pharmaceuticals Industries, Ltd Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
EP1587805B1 (de) * 2003-01-15 2009-04-22 Cipla Limited Pharmazeutisches verfahren und damit hergestellte verbindungen
JP2006518751A (ja) * 2003-02-20 2006-08-17 サンタラス インコーポレイティッド 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
EP1601667A2 (de) * 2003-03-12 2005-12-07 Teva Pharmaceutical Industries Limited Kristalline und amorphe festformen von pantoprazol und vervahren zu ihrer herstellung
EP1615913A2 (de) 2003-06-10 2006-01-18 Teva Pharmaceutical Industries Limited Verfahren zur herstellung von (pyridinyl)methyl]sulfinyl-substituierte benzimidazoles und neue chlorierte derivate von pantoprazole
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2531564C (en) * 2003-07-18 2016-01-19 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
TWI337877B (en) * 2003-07-18 2011-03-01 Santarus Inc Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
CN1946722A (zh) * 2004-04-28 2007-04-11 奥坦纳医药公司 二烷氧基咪唑并吡啶衍生物
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2570795C (en) * 2004-06-24 2013-05-28 Astrazeneca Ab Process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
GB0525710D0 (en) * 2005-12-17 2006-01-25 Pliva Hrvatska D O O An improved process for preparing of substituted 2-benzimidazolesulfoxide compounds
WO2008017020A2 (en) * 2006-08-03 2008-02-07 Dr. Reddy's Laboratories Limited Process for preparing proton pump inhibitors
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP2114919A2 (de) 2007-01-31 2009-11-11 Krka Tovarna Zdravil, D.D., Novo Mesto Verfahren zur herstellung von optisch reinem omeprazol durch salzbildung mit einem chiralen amin oder behandlung mit einem enantiomer umwandelnden enzym und chromatographische auftrennung
WO2010134099A1 (en) 2009-05-21 2010-11-25 Cadila Healthcare Limited One pot process for preparing omeprazole and related compounds
WO2013108068A1 (en) 2012-01-21 2013-07-25 Jubilant Life Sciences Limited Process for the preparation of 2-pyridinylmethylsulfinyl benzimidazoles, their analogs and optically active enantiomers

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4483781A (en) * 1983-09-02 1984-11-20 The Procter & Gamble Company Magnesium salts of peroxycarboxylic acids
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS61178919A (ja) * 1985-02-04 1986-08-11 Banyu Pharmaceut Co Ltd ベンズイミダゾ−ル誘導体およびそれを含有する医薬
JPS62201884A (ja) * 1986-02-28 1987-09-05 Tokyo Tanabe Co Ltd ベンズイミダゾール誘導体及びその製造法
JPH0643426B2 (ja) * 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
FI864046A (fi) * 1986-10-07 1988-04-08 Farmos Oy Foerfarande foer framstaellning av en terapeutiskt aktiv foerening.
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
AU2817989A (en) * 1987-12-11 1989-07-05 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel benzimidazole derivatives
SE8804628D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New compounds
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
FR2660313B1 (fr) * 1990-04-02 1992-07-03 Fournier Ind & Sante Nouveau sulfonyl-phenyl-betha-d-thioxylosides, leur procede de preparation et leur utilisation en therapeutique.

Also Published As

Publication number Publication date
CA2078517A1 (en) 1993-03-21
JPH0720956B2 (ja) 1995-03-08
US5391752A (en) 1995-02-21
AU649355B2 (en) 1994-05-19
DE69230278T2 (de) 2001-04-05
CN1071169A (zh) 1993-04-21
IL103156A0 (en) 1993-02-21
WO1993006097A1 (en) 1993-04-01
EP0533264A1 (de) 1993-03-24
MX9205333A (es) 1993-07-01
KR100242622B1 (ko) 2000-03-02
NZ244301A (en) 1994-08-26
AU2520792A (en) 1993-03-25
DE69230278D1 (de) 1999-12-16
YU89492A (sh) 1995-10-03
IL103156A (en) 1997-02-18
KR930006021A (ko) 1993-04-20
PT533264E (pt) 2000-05-31
EP0533264B1 (de) 1999-11-10
YU48291B (sh) 1998-05-15
JPH05213936A (ja) 1993-08-24
ES2143468T3 (es) 2000-05-16
CA2078517C (en) 2003-11-04
GR3032619T3 (en) 2000-05-31
DK0533264T3 (da) 2000-05-15
CN1048729C (zh) 2000-01-26

Similar Documents

Publication Publication Date Title
ATE186535T1 (de) Verfahren zur herstellung von omeprazol
DE3866617D1 (de) Verfahren zur herstellung von 2,3-pyridindicarbonsaeure-verbindungen.
DE3882055D1 (de) Verfahren zur herstellung von pyridin-2,3-dicarboxylsaeure-verbindungen.
DE3876473T2 (de) Verfahren zur herstellung von supraleitenden quanteninterferometern aus hochtemperatur-supraleitern.
DE68923468T2 (de) Verfahren zur Herstellung von Mehrschichtschaltungen.
DE69104750D1 (de) Verfahren zur Herstellung von Mehrschichtplatinen.
DE3772590D1 (de) Verfahren zur herstellung von 1,4-dihydropyridin-derivaten.
DE68916474D1 (de) Verfahren zur Herstellung von Polycarbonat.
DE58904566D1 (de) Verfahren zur herstellung von substituierten 2-chlorpyridinen.
DE3868194D1 (de) Verfahren zur transalkylierung von (polyalkyl)aromatischen kohlenwasserstoffen.
DE69023863D1 (de) Verfahren zur Herstellung von aromatischen Kohlenwasserstoffen.
DE69016273D1 (de) Verfahren zur Herstellung von aromatischen Kohlenwasserstoffen.
ATE70532T1 (de) Verfahren zur herstellung von oxiden von aromatischen tertiaeren aminen und so erhaltene produkte.
DE69011367T2 (de) Verfahren zur Herstellung von substituierten 2,3-Pyridindicarbonsäuren durch aufeinanderfolgende Oxidation von substituierten Chinolinen.
DE3667965D1 (de) Verfahren zur herstellung von hydroxycarbonyl-verbindungen aus 1,2-diolen.
DE68907821D1 (de) Verfahren zur herstellung von alkylsubstituierten aromatischen kohlenwasserstoffen.
DE3771153D1 (de) Verfahren zur herstellung von pyridin-2,3-dicarboxylsaeuren.
DE68901786D1 (de) Verfahren zur herstellung von alkylsubstituierten aromatischen kohlenwasserstoffen.
DE68902742T2 (de) Verfahren zur herstellung von 2,6-naphthalindicarbonsaeure.
DE3861897D1 (de) Verfahren zur herstellung von 4-hydroxy-2,2,6,6-tetramethyl-piperidin.
DE68923232D1 (de) Verfahren zur herstellung von pyridin-2,3-dicarbonsäure-verbindungen.
DE3869012D1 (de) Verfahren zur herstellung von aromatischen kohlenwasserstoffen.
DE3764494D1 (de) Verfahren zur herstellung von 4-acetyl-isochinolin-verbindungen.
DE69000280D1 (de) Verfahren zur herstellung von aromatischen kohlenwasserstoffen aus alkanen.
DE3887144D1 (de) Oxydationsverfahren für Herstellung von aromatischen Säuren aus alkylaromatischen Verbindungen.

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee